Nigerian First HoldCo to Sell Stake Held by Special Purpose Firm
'We will be disposing those shares and there are a range of options available to us,' Wale Oyedeji told an investor conference call in Lagos. 'Ultimately you will see that those shares will be disposed in the market,' he said without giving a timeline for the disposal.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Local Bounti (LOCL) Raises $10M and Cuts Debt with Convertible Note
Local Bounti Corporation (NYSE:LOCL) is one of the best NYSE penny stocks to invest in now. On August 4, the company announced that it had secured an additional $10 million in financing through the issuance of a convertible note with an existing investor. The note has a five-year maturity and an annual interest rate of 6.0%, payable in kind, meaning interest will be paid with additional securities rather than cash. Alongside this financing, Local Bounti amended its existing credit facility to reduce the principal balance by $10 million, effectively lowering its debt. As part of the transaction, the company will issue a warrant to the investor, which entitles the investor to purchase up to 550,000 shares of common stock at an exercise price of $0.125 per share. The terms of the company's senior debt facility remain consistent with those of previous restructuring agreements as of March 31, 2025. CEO Kathleen Valiasek highlighted that the new capital and debt reduction strengthen the company's balance sheet, positioning it for continued operational strength and growth. Local Bounti Corporation (NYSE:LOCL) is a U.S.-based controlled environment agriculture (CEA) company. It designs and operates indoor vertical farms to grow leafy greens and herbs. It leverages proprietary Stack & Flow technology to optimize crop yield, energy efficiency, and space utilization across its facilities in Montana, Georgia, and California. While we acknowledge the potential of LOCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Low-Priced Stocks to Buy Right Now and 11 Best Canadian Gold Stocks to Buy According to Hedge Funds. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
News24
an hour ago
- News24
Two more banks join Home Affairs branch blitz for IDs and passports
Two more banks have joined the partnership with Home Affairs to scale the number of branches that can facilitate passport and Smart ID applications. Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once. Show Comments ()
Yahoo
3 hours ago
- Yahoo
Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call
We recently published Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the worst-performing stocks on Tuesday. Summit Therapeutics tumbled by 9.08 percent on Tuesday to close at $25.68 apiece as investor sentiment was dampened by a dismal earnings performance as well as the absence of an investor call to elaborate on the results. Summit Therapeutics Inc. (NASDAQ:SMMT), which usually reports its quarterly earnings alongside an investor call, decided go without the latter on Monday. In the second quarter of the year, Summit Therapeutics Inc. (NASDAQ:SMMT) widened its net loss by 836 percent to $565.7 million from $60.4 million in the same period last year, as total operating expenses soared by 853 percent to $568.4 million from $59.6 million year-on-year. Net loss in the first half also expanded by 505 percent to $628.6 million from $103.9 million year-on-year, as total operating expenses jumped 522 percent to $635.3 million from $102 million. Copyright: nicoletaionescu / 123RF Stock Photo Summit Therapeutics Inc. (NASDAQ:SMMT) also skipped to comment on its financial and operating results. While we acknowledge the potential of SMMT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
